Curcumin blocks HIV protease inhibitor ritonavir-induced vascular dysfunction in porcine coronary arteries

Journal of the American College of Surgeons

Volumn 200, Issue 6, 2005, Pages 820-830

  Chai, Hong ^a   Yan, Shaoyu ^a   Lin, Peter ^a   Lumsden, Alan B ^a   Yao, Qizhi ^a   Chen, Changyi ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CURCUMIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE; PROTEINASE INHIBITOR; RITONAVIR; SUPEROXIDE;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL TONE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM; IMMUNOHISTOCHEMISTRY; MYOGRAPHY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SWINE; VASCULAR DISEASE; VASODILATATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CHEMILUMINESCENT MEASUREMENTS; CORONARY VESSELS; CURCUMIN; HIV PROTEASE INHIBITORS; IMMUNOHISTOCHEMISTRY; MYOGRAPHY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; POLYMERASE CHAIN REACTION; PROTEINS; RITONAVIR; RNA, MESSENGER; SUPEROXIDES; SWINE; VASOMOTOR SYSTEM;

EID: 19744369696     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2005.02.030     Document Type: Article

References (49)

1. F.J. Palella Jr, K.M. Delaney, A.C. Moorman HIV Outpatient Study Investigators Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection N Engl J Med 338 1998 853 860
2. D.C. Rhew, M. Bernal, D. Aguilar Association between protease inhibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus a systematic review Clin Infect Dis 37 2003 959 972
3. L. Calza, R. Manfredi, F. Chiodo Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy epidemiology, pathogenesis, clinical course and management Int J Antimicrob Agents 22 2003 89 99
4. J.H. Stein, M.A. Klein, J.L. Bellehumeur Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction Circulation 104 2001 257 262
5. H.P. Ammon, M.A. Wahl Pharmacology of Curcuma longa Planta Med 57 1991 1 7
6. M.T. Huang, H.L. Newmark, K. Frenkel Inhibitory effects of curcumin on tumorigenesis in mice J Cell Biochem 27 1997 26 34
7. Z.M. Shao, Z.Z. Shen, C.H. Liu Curcumin exerts multiple suppressive effects on human breast carcinoma cells Int J Cancer 98 2002 234 240
8. H. Inano, M. Onoda, N. Inafuku Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with gamma-rays Carcinogenesis 20 1999 1011 1018
9. R. Motterlini, R. Foresti, R. Bassi, C.J. Green Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress Free Radic Biol Med 28 2000 1303 1312
10. W. Lukita-Atmadja, Y. Ito, G.L. Baker, R.S. McCuskey Effect of curcuminoids as anti-inflammatory agents on the hepatic microvascular response to endotoxin Shock 17 2002 399 403
11. B. Fuller, S. Dijk, P. Butler Pro-inflammatory agents accumulate during donor liver cold preservation a study on increased adhesion molecule expression and abrogation by curcumin in cultured endothelial cells Cryobiology 46 2003 284 288
12. 2) quencher Biochem Biophys Res Commun 295 2002 62 66
13. N. Chainani-Wu Safety and anti-inflammatory activity of curcumin a component of tumeric (Curcuma longa) J Altern Complement Med 9 2003 161 168
14. D.S. Zhong, X.H. Lu, B.S. Conklin HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells Arterioscler Thromb Vasc Biol 22 2002 1560 1566
15. B. Conklin, W. Fu, P. Lin HIV protease inhibitor ritonavir decreases endothelium-dependent vaso-relaxation and increases superoxide in porcine arteries Cardiovasc Res 63 2004 168 175
16. M.E. Staff Physicians' desk reference 2003 57th ed. 2003 Medical Economics Montvale, NJ
17. W. Fu, B.S. Conklin, P.H. Lin Red wine prevents homocysteine-induced endothelial dysfunction in porcine coronary arteries J Surg Res 115 2003 82 91
18. S.M. Surowiec, B.S. Conklin, J.S. Li A new perfusion culture system used to study human vein J Surg Res 88 2000 34 41
19. Y. Sasaki, H. Goto, C. Tohda Effects of curcuma drugs on vasomotion in isolated rat aorta Biol Pharm Bull 26 2003 1135 1143
20. National Toxicology Program. NTP toxicology and carcinogenesis studies of turmeric oleoresin (CAS No. 8024-37-1) (Major Component 79%-85% Curcumin, CAS No. 458-37-7) in F344/N Rats and B6C3F1 Mice (Feed Studies) Natl Toxicol Program Tech Rep Ser 427 1993 1 275
21. S. Rafatullah, M. Tariq, M.A. Al-Yahya Evaluation of turmeric (Curcuma longa) for gastric and duodenal antiulcer activity in rats J Ethnopharmacol 29 1990 25 34
22. Z.S. Nedeljkovic, N. Gokce, J. Loscalzo Mechanisms of oxidative stress and vascular dysfunction Postgrad Med J 79 2003 195 199
23. H. Cai, D.G. Harrison Endothelial dysfunction in cardiovascular diseases the role of oxidant stress Circ Res 87 2000 840 844
24. J.N. Wilcox, R.R. Subramanian, C.L. Sundell Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels Arterioscler Thromb Vasc Biol 17 1997 2479 2488
25. V. Berka, A.L. Tsai Characterization of interactions among the heme center, tetrahydrobiopterin, and l-arginine binding sites of ferric eNOS using imidazole, cyanide, and nitric oxide as probes Biochemistry 39 2000 9373 9383
26. S. Pou, W. Pou, D. Bredt Generation of superoxide by purified brain nitric oxide synthase J Biol Chem 267 1992 24173 24176
27. H. Shimokawa, N.A. Flavahan, P.M. Vanhoutte Loss of endothelial pertussis toxin-sensitive G protein function in atherosclerotic porcine coronary arteries Circulation 83 1991 652 660
28. D.G. Harrison Endothelial function and oxidant stress Clin Cardiol 20 1997 II11 II17
29. J.W. Heinecke Oxidants and antioxidants in the pathogenesis of atherosclerosis implications for the oxidized low density lipoprotein hypothesis Atherosclerosis 141 1998 1 15
30. M.N. Diaz, B. Frei, J.A. Vita, J. Keaney Jr Antioxidants and atherosclerotic heart disease N Engl J Med 337 1997 408 416
31. R.M. Wever, T.F. Luscher, F. Cosentino, T.J. Rabelink Atherosclerosis and the two faces of endothelial nitric oxide synthase Circulation 97 1998 108 112
32. U. Forstermann, J.P. Boissel, H. Kleinert Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III) FASEB J 12 1998 773 790
33. U. Landmesser, S. Dikalov, S.R. Price Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension J Clin Invest 111 2003 1201 1209
34. G.N. Welch, J. Loscalzo Homocysteine and atherothrombosis N Engl J Med 338 1998 1042 1050
35. M. Usui, H. Matsuoka, H. Miyazaki Endothelial dysfunction by acute hyperhomocyst(e)inaemia restoration by folic acid Clin Sci 96 1999 235 239
36. J. Leiper, P. Vallance Biological significance of endogenous methylarginines that inhibit nitric oxide synthases Cardiovasc Res 43 1999 542 548
37. H. Miyazaki, H. Matsuoka, J.P. Cooke Endogenous nitric oxide synthase inhibitor a novel marker of atherosclerosis Circulation 99 1999 1141 1146
38. R.C. Srimal, B.N. Dhawan, R.R. Satoskar Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent J Pharm Pharmacol 25 1973 447 452
39. O.P. Sharma, A.J. Ruby, G. Kuttan Antioxidant activity of curcumin and related compounds Biochem Pharmacol 25 1976 1811 1812
40. R.R. Satoskar, S.J. Shah, S.G. Shenoy Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation Int J Clin Pharmacol Ther Toxicol 24 1986 651 654
41. A. Viaje, T.J. Slaga, M. Wigler, I.B. Weinstein Effects of antiinflammatory agents on mouse skin tumor promotion, epidermal DNA synthesis, phorbol ester-induced cellular proliferation, and production of plasminogen activator Cancer Res 37 1977 1530 1536
42. M.T. Huang, R.C. Smart, C.Q. Wong, A.H. Conney Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate Cancer Res 48 1988 5941 5946
43. A.C. Reddy, B.R. Lokesh Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous iron Mol Cell Biochem 137 1994 1 8
44. A.J. Ruby, G. Kuttan, K.D. Babu Anti-tumour and antioxidant activity of natural curcuminoids Cancer Lett 94 1995 79 83
45. E.J. Freireich, E.A. Gehan, D.P. Rall Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey and man Cancer Chemother Rep 50 1966 219 244
46. K.B. Soni, R. Kuttan Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers Indian J Physiol Pharmacol 36 1992 273 275
47. S.D. Deodhar, R. Sethi, R.C. Srimal Preliminary study on antirheumatic activity of curcumin (diferuloyl methane) Indian J Med Res 71 1980 632 634
48. R.R. Satoskar, S.J. Shah, S.G. Shenoy Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with post-operative inflammation Int J Clin Pharmacol Ther Toxicol 24 1986 651 654
49. A.L. Cheng, C.H. Hsu, J.K. Lin Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions Anticancer Res 21 2001 2895 2900